This disclosure relates to a novel process for producing 7-(substituted)-amino-3-substituted thiomethyl- DELTA 3-cephem-4-carboxylic acids which are intermediate products of cephalosporins being valuable antibacterial compounds for use in mammals including man.
展开▼